These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29313817)

  • 21. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
    Lee CH; Choi SW; Jun SW; Hwang J; Kim IC; Cho YK; Park HS; Yoon HJ; Kim H; Nam CW; Han S; Kim KB; Hur SH
    PLoS One; 2020; 15(6):e0234362. PubMed ID: 32520973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.
    Konigstein M; Ben-Yehuda O; Smits PC; Love MP; Banai S; Perlman GY; Golomb M; Ozan MO; Liu M; Leon MB; Stone GW; Kandzari DE
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2467-2476. PubMed ID: 30573057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
    Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
    Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention.
    Tailakh MA; Friger M; Zahger D; Sidi A; Mazor-Dray E; Novack V
    Eur J Intern Med; 2017 Jan; 37():69-74. PubMed ID: 27665509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study.
    Xing FY; Neeland IJ; Gore MO; Ayers CR; Paixao AR; Turer AT; Berry JD; Khera A; de Lemos JA; McGuire DK
    Diab Vasc Dis Res; 2014 Jan; 11(1):11-8. PubMed ID: 24344119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Big Endothelin-1 and long-term all-cause death in patients with coronary artery disease and prediabetes or diabetes after percutaneous coronary intervention.
    Xu N; Zhu P; Yao Y; Jiang L; Jia S; Yuan D; Xu J; Wang H; Song Y; Gao L; Gao Z; Song L; Zhao X; Chen J; Yang Y; Xu B; Gao R; Yuan J
    Nutr Metab Cardiovasc Dis; 2022 Sep; 32(9):2147-2156. PubMed ID: 35843800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of hemoglobin A1c for the identification of individuals with diabetes and prediabetes in a Chinese high risk population.
    Yang C; Liu Y; Li X; Liang H; Jiang X
    Scand J Clin Lab Invest; 2012 Sep; 72(5):403-9. PubMed ID: 22640413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
    Nusca A; Tuccinardi D; Proscia C; Melfi R; Manfrini S; Nicolucci A; Ceriello A; Pozzilli P; Ussia GP; Grigioni F; Di Sciascio G
    Cardiovasc Diabetol; 2019 Nov; 18(1):147. PubMed ID: 31706305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased arterial stiffness in subjects with pre-diabetes among middle aged population in Beijing, China.
    Shen L; Zhang YG; Liu M; Qiang DC; Sun XL; Liu L; Jiang YY
    Biomed Environ Sci; 2013 Sep; 26(9):717-25. PubMed ID: 24099605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HbA1c alone is a poor indicator of cardiometabolic risk in middle-aged subjects with pre-diabetes but is suitable for type 2 diabetes diagnosis: a cross-sectional study.
    Millar SR; Perry IJ; Phillips CM
    PLoS One; 2015; 10(8):e0134154. PubMed ID: 26266799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Scicali R; Giral P; Gallo A; Di Pino A; Rabuazzo AM; Purrello F; Cluzel P; Redheuil A; Bruckert E; Rosenbaum D
    Atherosclerosis; 2016 Dec; 255():102-108. PubMed ID: 27870948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Baber U; Stefanini GG; Giustino G; Stone GW; Leon MB; Sartori S; Aquino M; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; von Birgelen C; Dangas GD; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007734. PubMed ID: 31288561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
    Åkerblom A; Wojdyla D; Steg PG; Wallentin L; James SK; Budaj A; Katus HA; Himmelmann A; Huber K; Siegbahn A; Storey RF; Becker RC;
    J Thromb Thrombolysis; 2019 Nov; 48(4):563-569. PubMed ID: 31512201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of progression to diabetes from prediabetes defined by HbA1c or fasting plasma glucose criteria in Koreans.
    Kim CH; Kim HK; Kim EH; Bae SJ; Choe J; Park JY
    Diabetes Res Clin Pract; 2016 Aug; 118():105-11. PubMed ID: 27368062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
    Kharroubi AT; Darwish HM; Abu Al-Halaweh AI; Khammash UM
    PLoS One; 2014; 9(2):e88123. PubMed ID: 24505401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediabetes and risk of active tuberculosis: a cohort study from Northern Taiwan.
    Ko TH; Chang YC; Chang CH; Liao KC; Magee MJ; Lin HH
    Int J Epidemiol; 2023 Jun; 52(3):932-941. PubMed ID: 36350563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.